BSE filing, NSE: GRASIM. Summary written from the filing by ALFA Finder's alert engine.
Grasim Industries Ltd: key numbers
- Share price
- ₹2,900.00
- Market cap
- ₹1,97,351 Cr
- Revenue (annual)
- ₹1,75,431 Cr
- Net profit (annual)
- ₹4,966 Cr
- P/E (TTM)
- 34.7×Sector 31.3×
- Promoter holding
- 45.20%+1.46% QoQ
- FII holding
- 14.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Grasim Industries Ltd
All →Grasim Industries Debt & Borrowing: ₹750 Cr
Grasim Industries repaid ₹750 Crore of Commercial Paper (ISIN INE047A14BE6) at maturity on 26 Oct 2026. Outstanding CP amount is now Nil.
- Value
- ₹750.0 Cr
Grasim Industries Legal & Regulatory
Grasim replied to exchange queries on a news item. The Bombay HC quashed the Rs 329 crore reassessment notice, with no demand or financial impact.
Grasim Industries Production Started
Grasim Industries has commenced commercial production at its Epichlorohydrin plant in Vilayat, Gujarat, with a capacity of 50 K TPA. This strengthens its downstream chlor-alkali derivatives portfolio.
- epichlorohydrin (ECH) manufacturing capacity
- 50000 TPA
Grasim Industries Other Announcement
Grasim Industries Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI listing regulations.
Grasim Industries Debt & Borrowing
Grasim Industries submitted its half-yearly statement of outstanding Non-Convertible Debentures as of 30th September 2026, complying with SEBI circular requirements for debt securities.
Grasim Industries Other Announcement
Grasim Industries filed a CFO certificate confirming the utilization of proceeds from commercial papers issued during the quarter ended 30th September 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date